What is Veracyte's operating cash flow?

Veracyte (VCYT) reported operating cash flow of $35.22M in Q1 2026.

How has Veracyte's operating cash flow changed year-over-year?

Veracyte's operating cash flow increased by 556.8% year-over-year, from $5.36M to $35.22M.

What is the long-term trend for Veracyte's operating cash flow?

Over 3 years (2022 to 2025), Veracyte's operating cash flow has grown at a 162.5% compound annual growth rate (CAGR), from $7.54M to $136.31M.

What does operating cash flow mean?

Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.

Veracyte VCYT Operating Cash Flow

Operating Cash Flow at other companies

Guardant HealthGH

-$65.62M-4.7%

Natera, Inc.NTRA

$40.17M-9.6%

Bio-Rad LaboratoriesBIO

$108.1M-16.8%

RevvityRVTY

$115.23M-10.1%

Labcorp HoldingsLH

$191.5M+935%

Quest DiagnosticsDGX

$278M-11.5%

Other financials

Income statement

See full

Revenue$139.1M+21.5%

Gross profit$101.2M+27.2%

Operating income$22.6M+680%

Net income$28.7M+307%

EPS (diluted)$0.35+289%

Balance sheet

See full

Cash & equivalents$264.8M+41.0%

Total debt$39.3M-22.1%

Total equity$1.3B+12.5%

Total assets$1.4B+9.2%

Cash flow

See full

CapEx$3.0M+62.8%

Free cash flow$32.3M+810%

Valuation

See full

Market cap$4.28B+10.7%

Enterprise value$4.05B+7.4%

P/E48.6×-68.3×

P/S7.9×-0.4×

Profitability

See full

Gross margin70.9%+2.9pp

Operating margin14.3%+9.2pp

Net margin16.2%+9.1pp

FCF margin28.7%+11.7pp

Returns & leverage

See full

Return on equity6.9%+4.1pp

Debt / equity0×0.0×

Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.

The official record: Veracyte’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Veracyte's operating cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Veracyte's operating cash flow?: Veracyte (VCYT) reported operating cash flow of $35.22M in Q1 2026.
How has Veracyte's operating cash flow changed year-over-year?: Veracyte's operating cash flow increased by 556.8% year-over-year, from $5.36M to $35.22M.
What is the long-term trend for Veracyte's operating cash flow?: Over 3 years (2022 to 2025), Veracyte's operating cash flow has grown at a 162.5% compound annual growth rate (CAGR), from $7.54M to $136.31M.
What does operating cash flow mean?: Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.